CELLECTAR BIOSCIENCES INC
CLRB·15117F880·US·Common Stock·Healthcare - Biotechnology-13D/G
CLRB (CELLECTAR BIOSCIENCES INC) is held by 14 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($207,985), GEODE CAPITAL MANAGEMENT, LLC ($134,062), Sequoia Financial Advisors, LLC ($47,879). Net institutional sentiment: Mixed.
14
Holders
Avg rating(2 Elite)
$471,504
Total Value
55% (17)
Fund Consensus
6 buying - 5 selling
Who's Trading
ActivistSTStonepine Capital Management, LLC9.9%May 11, 2026
InsiderLJLongcor JarrodBuy $25KMay 7, 2026
InsiderCVCARUSO JAMES VBuy $25KMay 7, 2026
ActivistBLBleichroeder LP4.6%Feb 13, 2026
ActivistRARosalind Advisors, Inc.5.5%Feb 10, 2026
ActivistHEHexstone Capital LLC4.9%Feb 4, 2026
InsiderNJNEIS JOHNSell $731.99Dec 12, 2025
ActivistLLLYTTON LAURENCE W1.6%Aug 14, 2025
InsiderLJLongcor JarrodBuy $50KJul 2, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer